*Result*: Guselkumab is superior to fumaric acid esters in patients with moderate‐to‐severe plaque psoriasis who are naive to systemic treatment: results from a randomized, active‐comparator‐controlled phase IIIb trial (POLARIS)
*Author/editor-in-chief*:
Thaci, Diamant (Verfasser); Pinter, Andreas (Verfasser) ; Sebastian, Michael (Verfasser); Termeer, Christian C. (Verfasser) ; Sticherling, Michael (Verfasser) ; Gerdes, Sascha (Verfasser) ; Wegner, Sven (Verfasser); Krampe, Stefanie (Verfasser) ; Bartz, Holger (Verfasser) ; Rausch, Christian (Verfasser); Mensch, Alexander (Verfasser); Eyerich, Kilian (Verfasser)
*Publication*:
Freiburg : Universität, 2021
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
British journal of dermatology. - 183, 2 (2020) , 265-275, ISSN: 1365-2133
*DOI*:
10.1111/bjd.18696